Trial Outcomes & Findings for Dosing Music for Anxiety Reduction in Parturients (NCT NCT05966766)

NCT ID: NCT05966766

Last Updated: 2025-05-30

Results Overview

Verbally rated anxiety on numeric rating scale (NRS) of 0-10, before and after intervention. A rating of 0 meant the patient had no anxiety, while a rating of 10 meant the patient had the worst anxiety possible. Must have been at least a 1-point decrease between pre- and post-intervention scores to be considered a positive response, larger decrease meant a better outcome.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

40 participants

Primary outcome timeframe

4-8 minutes

Results posted on

2025-05-30

Participant Flow

Participant milestones

Participant milestones
Measure
Mozart
Subjects in this arm will listen to music from a list of pre-selected pieces by Mozart that have been previously shown to have beneficial effects on anxiety.
Patient Preference
Subjects in this arm will listen to music from a list of pre-selected pieces of their own choosing.
Overall Study
STARTED
20
20
Overall Study
COMPLETED
20
20
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Dosing Music for Anxiety Reduction in Parturients

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Mozart
n=20 Participants
Subjects in this arm listened to music from a list of pre-selected pieces by Mozart that have been previously shown to have beneficial effects on anxiety.
Patient Preference
n=20 Participants
Subjects in this arm listened to music from a list of pre-selected pieces of their own choosing.
Total
n=40 Participants
Total of all reporting groups
Age, Continuous
32.7 Years
STANDARD_DEVIATION 5.4 • n=5 Participants
33.5 Years
STANDARD_DEVIATION 4.9 • n=7 Participants
33.0 Years
STANDARD_DEVIATION 5.1 • n=5 Participants
Sex: Female, Male
Female
20 Participants
n=5 Participants
20 Participants
n=7 Participants
40 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
n=5 Participants
4 Participants
n=7 Participants
8 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
16 Participants
n=5 Participants
16 Participants
n=7 Participants
32 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
8 Participants
n=5 Participants
5 Participants
n=7 Participants
13 Participants
n=5 Participants
Race (NIH/OMB)
White
10 Participants
n=5 Participants
12 Participants
n=7 Participants
22 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Gestational age
38.6 Weeks
STANDARD_DEVIATION 0.8 • n=5 Participants
38.6 Weeks
STANDARD_DEVIATION 0.9 • n=7 Participants
38.6 Weeks
STANDARD_DEVIATION 0.9 • n=5 Participants
Gravidity
2.4 Pregnancies
STANDARD_DEVIATION 1 • n=5 Participants
3.6 Pregnancies
STANDARD_DEVIATION 1.3 • n=7 Participants
3 Pregnancies
STANDARD_DEVIATION 2.2 • n=5 Participants
Parity
1.1 Births
STANDARD_DEVIATION 0.8 • n=5 Participants
1.3 Births
STANDARD_DEVIATION 1.4 • n=7 Participants
1.2 Births
STANDARD_DEVIATION 1.1 • n=5 Participants

PRIMARY outcome

Timeframe: 4-8 minutes

Verbally rated anxiety on numeric rating scale (NRS) of 0-10, before and after intervention. A rating of 0 meant the patient had no anxiety, while a rating of 10 meant the patient had the worst anxiety possible. Must have been at least a 1-point decrease between pre- and post-intervention scores to be considered a positive response, larger decrease meant a better outcome.

Outcome measures

Outcome measures
Measure
Mozart
n=20 Participants
Subjects in this arm will listen to music from a list of pre-selected pieces by Mozart that have been previously shown to have beneficial effects on anxiety.
Patient Preference
n=20 Participants
Subjects in this arm will listen to music from a list of pre-selected pieces of their own choosing.
Anxiety Score
Before
5.9 score on a scale
Standard Deviation 2.6
6.1 score on a scale
Standard Deviation 2.3
Anxiety Score
After
3.6 score on a scale
Standard Deviation 2.3
3.1 score on a scale
Standard Deviation 2.4

SECONDARY outcome

Timeframe: 4-8 minutes

6-question abbreviated state-trait anxiety inventory (STAI) questions asked and scored on a 6-24 point scale (higher is more anxiety) for before and after intervention. Decrease in score after intervention was considered a positive response, with larger decreases indicating better responses.

Outcome measures

Outcome measures
Measure
Mozart
n=20 Participants
Subjects in this arm will listen to music from a list of pre-selected pieces by Mozart that have been previously shown to have beneficial effects on anxiety.
Patient Preference
n=20 Participants
Subjects in this arm will listen to music from a list of pre-selected pieces of their own choosing.
STAI
Before
12.7 score on a scale
Standard Deviation 4.3
14.4 score on a scale
Standard Deviation 4.1
STAI
After
10.3 score on a scale
Standard Deviation 3.2
10.8 score on a scale
Standard Deviation 3.2

Adverse Events

Mozart

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Patient Preference

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dan Drzymalski, MD

Tufts Medical Center

Phone: 617-913-8168‬‬‬‬‬‬‬‬‬‬‬‬‬‬

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place